LLLawan Larsuprom

Lawan Larsuprom

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lawan Larsuprom has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Chalermpol Lekcharoensuk

    Department of Companion Animal Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand

    1 shared publication
  • Chantima Pruksakorn

    Department of Microbiology and Immunology, Faculty of Veterinary Medicine, Kasetsart University, 50 Ngamwongwan Rd., Bangkok 10900, Thailand

    1 shared publication
  • Charles Chen

    Asian Veterinary Specialist Referral Center, 1F No.109 Section 4 Xin Yi road, Taipei, Taiwan

    1 shared publication
  • Nutchaphon Rungroj

    Department of Microbiology and Immunology, Kasetsart University, 50 Ngamwongwan Road, Chatuchak, Bangkok, 10900, Thailand

    1 shared publication
  • Sumet Kongkiatpaiboon

    Drug Discovery and Development Center, Thammasat University (Rangsit Campus), Pathumthani, 12121, Thailand

    1 shared publication
  • Udomlak Sukatta

    Department of Microbiology and Immunology, Kasetsart University, 50 Ngamwongwan Road, Chatuchak, Bangkok, 10900, Thailand

    1 shared publication

Latest Publications

  • In vitro antibacterial activity of mangosteen (Garcinia mangostana Linn.) crude extract against Staphylococcus pseudintermedius isolates from canine pyoderma

    by Lawan Larsuprom, Nutchaphon Rungroj, Chalermpol Lekcharoensuk, Chantima Pruksakorn, Sumet Kongkiatpaiboon, Charles Chen, Udomlak Sukatta

    Background: Staphylococcus pseudintermedius, commonly involved in canine pyoderma, can be classified as meticillin‐susceptible S. pseudintermedius (MSSP) or meticillin‐resistant S. pseudintermedius (MRSP). MRSP infections may be difficult to treat due to broad β‐lactam resistance of MRSP and typically additional multidrug‐resistance. Topical antibacterial treatment is the preferred treatment modality for surface and superficial skin infections.Hypothesis⁄objectives: Mangosteen crude extract containing the antibacterial compound α‐mangostin will have in vitro activity against MSSP and MRSP isolated from canine pyoderma.Bacterial isolates: Twenty‐three samples, MSSP (n = 12) and MRSP (n = 11), isolated from canine pyoderma.Methods and materials: Minimum inhibitory concentrations (MICs) were determined for mangosteen crude extract by broth microdilution. High‐performance liquid chromatography (HPLC) analysis was used to determine the amount of α‐mangostin in mangosteen crude extract. A time‐kill assay was performed at 30 min and 2 h after exposure to a high concentration of crude extract (100× MIC). Antibacterial activity for α‐mangostin was calculated according to HPLC results.Results: The concentration of α‐mangostin was 17.72 ± 1.42% w/w. The mean MIC of α‐mangostin towards MSSP was 0.53 ± 0.35 μg/mL, whereas the mean value for MRSP was 0.47 ± 0.27 μg/mL. There was no difference between the mean MIC of MRSP and MSSP (P = 0.84). After a 30 min exposure to 100× MIC of the crude extract, a 95% reduction in colony forming units was found.Conclusions and clinical importance: The results showed that α‐mangostin in mangosteen crude extract was effective in inhibiting S. pseudintermedius (both MRSP and MSSP). Clinical studies are needed to investigate this effectiveness further in vivo.